SEARCH

SEARCH BY CITATION

References

  • 1
    Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin. Liver Dis. 2005; 9: 191211.
  • 2
    Okuda K, Ohtsuki T, Obata H et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985; 56: 91828.
  • 3
    Stuart KE, Anad AJ, Jenkins RL. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 1996; 77: 221722.
  • 4
    Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 120836.
  • 5
    Hong K, Geordiades CS, Geschwind JFH. Technology insight: image-guided therapies for hepatocellular carcinoma-intra-arterial and ablative techniques. Oncology 2006; 3: 31524.
  • 6
    Jansen MC, Hillegersberg RV, Chamuleau RFFM et al. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur. J. Surg. Oncol. 2005; 31: 33144.
  • 7
    Poon RT, Fat ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann. Surg. 2002; 235: 46686.
  • 8
    Dodd GD III, Soulen MC, Kane RA et al. Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics 2000; 20: 927.
  • 9
    Pang RW, Poon RT. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now. Oncology 2007; 72 (Suppl. 1): 3044.
  • 10
    Chen MH, Wei Y, Yan K et al. Treatment strategy to optimize radiofrequency ablation for liver malignancies. J. Vasc. Interv. Radiol. 2006; 17: 67183.
  • 11
    Lim HK. Radiofrequency thermal ablation of hepatocellular carcinomas. Korean J. Radiol. 2000; 1: 17584.
  • 12
    Lim HK, Choi D, Lee WJ et al. Hepatocellular carcinoma treated with percutaneous radiofrequency ablation: evaluation with follow-up multiphase helical CT. Radiology 2001; 221: 44754.
  • 13
    Choi D, Lim HK, Kim SH et al. Assessment of therapeutic response in hepatocellular carcinoma treated with percutaneous radiofrequency ablation: comparison of multiphase helical computed tomography and power Doppler ultrasonography with a microbubble contrast agent. J. Ultrasound Med. 2002; 21: 391401.
  • 14
    Choi D, Lim HK, Kim SH et al. Hepatocellular carcinoma treated with percutaneous radiofrequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology 2000; 217: 55863.
  • 15
    Kim TS, Lim HK, Kim H. Imaging-guided percutaneous radiofrequency ablation of pulmonary metastatic nodules caused by hepatocellular carcinoma: preliminary experience. AJR Am. J. Roentgenol. 2003; 181: 4914.
  • 16
    Kim SK, Lim HK, Kim YH et al. Hepatocellular carcinoma treated with radiofrequency ablation: spectrum of imaging findings. Radiographics 2003; 23: 10721.
  • 17
    Choi D, Lim HK, Lee WJ et al. Early assessment of the therapeutic response to radiofrequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent. J. Ultrasound Med. 2003; 22: 116372.
  • 18
    Rhim H, Yoon KH, Lee JM et al. Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings. Radiographics 2003; 23: 12334; discussion 134–6.
  • 19
    Kim SH, Lim HK, Choi D et al. Changes in bile ducts after radiofrequency ablation of hepatocellular carcinoma: frequency and clinical significance. AJR Am. J. Roentgenol. 2004; 183: 16117.
  • 20
    Choi D, Lim HK, Kim MJ et al. Therapeutic efficacy and safety of percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the gastrointestinal tract. AJR Am. J. Roentgenol. 2004; 183: 141724.
  • 21
    Choi D, Lim HK, Lee WJ et al. Radiofrequency ablation of liver cancer: early evaluation of therapeutic response with contrast-enhanced ultrasonography. Korean J. Radiol. 2004; 5: 18598.
  • 22
    Choi D, Lim HK, Rhim H et al. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. Radiology 2004; 230: 13541.
  • 23
    Kim CK, Choi D, Lim HK et al. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur. J. Radiol. 2005; 56: 6673.
  • 24
    Choi D, Lim HK, Kim MJ et al. Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinomas: frequency and risk factors. AJR Am. J. Roentgenol. 2005; 184: 18607.
  • 25
    Hong SN, Lee SY, Choi MS et al. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J. Clin. Gastroenterol. 2005; 39: 24752.
  • 26
    Choi D, Lim HK, Rhim H et al. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors. Ann. Surg. Oncol. 2007; 14: 231929.
  • 27
    Choi D, Lim HK, Rhim H et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur. Radiol. 2007; 17: 68492.
  • 28
    Choi D, Lim HK, Joh JW et al. Combined hepatectomy and radiofrequency ablation for multifocal hepatocellular carcinomas: long-term follow-up results and prognostic factors. Ann. Surg. Oncol. 2007; 14: 35108.
  • 29
    Rhim H, Lim HK, Kim YS, Choi D, Lee KT. Local tumor progression after radiofrequency ablation of liver tumors: analysis of morphologic pattern and site of recurrence. AJR Am. J. Roentgenol 2008; 190: 154451.
  • 30
    Kim YS, Rhim H, Lim HK et al. Completeness of treatment in hepatocellular carcinomas treated with image-guided tumor therapies: evaluation of positive predictive value of contrast-enhanced CT with histopathologic correlation in the explanted liver specimen. J. Comput. Assist. Tomogr. 2006; 30: 57882.
  • 31
    Kim MH, Choi MS, Choi YS et al. Clinical features of liver abscess developed after radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma. Korean J. Hepatol. 2006; 12: 5564.
  • 32
    Kim SH, Lim HK, Choi D et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results. AJR Am. J. Roentgenol. 2006; 186: S32733.
  • 33
    Rhim H, Lim HK, Kim YS, Choi D. Percutaneous radiofrequency ablation of hepatocellular adenoma: initial experience in 10 patients. J. Gastroenterol. Hepatol. 2007 Oct 17. [Epub ahead of print.
  • 34
    Kim YS, Rhim H, Lim HK, Choi D, Lee WJ, Kim SH. Hepatic infarction after radiofrequency ablation of hepatocellular carcinoma with an internally cooled electrode. J. Vasc. Interv. Radiol. 2007; 18: 112633.
  • 35
    Kim SH, Lim HK, Kim MJ, Choi D, Rhim H, Park CK. Radiofrequency ablation of high-grade dysplastic nodules in chronic liver disease: comparison with well-differentiated hepatocellular carcinoma based on long-term results. Eur. Radiol. 2007; 18: 81421.
  • 36
    Rhim H, Goldberg SN, Dodd GB 3rd et al. Essential techniques for successful radiofrequency thermal ablation of malignant hepatic tumors. Radiographics 2001; 21 Spec No: S1735.
  • 37
    Lecioni R, Cioni D, Crocetti L et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234: 9617.
  • 38
    Tateishi R, Shiina S, Teratani T et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005; 103: 1201.
  • 39
    Livraghi T, Meloni F, DiStasi M et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 2007; 47: 829.
  • 40
    Yan K, Chen MH, Yang W et al. Radiofrequency ablation of hepatocellular carcinoma: Long-term outcome and prognostic factors. Eur. J. Radiol. 2007; 67: 33647.
  • 41
    Livraghi T, Solbiati L, Meloni MF et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226: 44151.
  • 42
    Wakabayashi H, Ushiyama T, Ishimura K et al. Significance of reduction surgery in multidisciplinary treatment of advance hepatocellular carcinoma with multiple intrahepatic lesions. J. Surg. Oncol. 2003; 82: 98103.
  • 43
    Raut CP, Izzo F, Marra P et al. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann. Surg. Oncol. 2005; 12: 61628.
  • 44
    Elias D, De Baere T, Smayra T, Ouellet JF, Roche A, Lasser P. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumor recurrence after hepatectomy. Br. J. Surg. 2002; 89: 7526.
  • 45
    Lu MD, Yin XY, Xie XY et al. Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy. Br. J. Surg. 2005; 92: 13938.
  • 46
    Chen MS, Li JQ, Zheng Y et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann. Surg. 2006; 243: 3218.
  • 47
    Lu MD, Kuang M, Liang LJ et al. Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial. Zhonghua Yi Xue Za Zhi 2006; 86: 8015.
  • 48
    McGahan JP, Dodd GD III. Radiofrequency ablation of the liver: current status. AJR Am. J. Roentgenol. 2001; 176: 316.
  • 49
    Goldberg SN, Grassi CJ, Cardella JF et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005; 235: 72839.
  • 50
    Schwartz ME, Sung ME, Mor E et al. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J. Am. Coll. Surg. 1995; 180: 596603.
  • 51
    Chen MH. Radiofrequency ablation of problematically located hepatocellular carcinoma: tailored approach. Abdom. Imaging 2008; 33: 42836.
  • 52
    Mulier S, Mulier P, Ni Y et al. Complications of radiofrequency coagulation of liver tumours. Br. J. Surg. 2002; 89: 120622.
  • 53
    Rhim H, Dodd DG III, Chintapalli KN et al. Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics 2004; 24: 4152.
  • 54
    Rhim H. Complications of radiofrequency ablation in hepatocellular carcinoma. Abdom. Imaging 2005; 30: 40918.
  • 55
    Kim SK, Rhim H, Kim YS et al. Radiofrequency thermal ablation of hepatic tumors: pitfalls and challenges. Abdom. Imaging 2005; 30: 72733.
  • 56
    Machi J, Uchida S, Sumida K et al. Ultrasound-guided radiofrequency thermal ablation of liver tumors: percutaneous, laparoscopic, and open surgical approaches. J. Gastrointest. Surg. 2001; 5: 47789.
  • 57
    Koda M, Ueki M, Maeda Y et al. Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm. AJR Am. J. Roentgenol. 2004; 183: 5838.
  • 58
    De Baere T, Dromain C, Lapeyre M et al. Artificially induced pneumothorax for percutaneous transthoracic radiofrequency ablation of tumors in the hepatic dome: initial experience. Radiology 2005; 236: 66670.
  • 59
    Rhim H, Lim HK, Kim YS, Choi D. Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience. AJR Am. J. Roentgenol. 2008; 190: 918.
  • 60
    Laeseke PF, Sampson LA, Brace CL, Winter TC 3rd, Fine JP, Lee FT Jr. Unintended thermal injuries from radiofrequency ablation: protection with 5% dextrose in water. AJR Am. J. Roentgenol. 2006; 186 (5 Suppl.): S24954.
  • 61
    Hinshaw JL, Laeseke PF, Winter TC 3rd, Kliewer MA, Fine JP, Lee FT Jr. Radiofrequency ablation of peripheral liver tumors: intraperitoneal 5% dextrose in water decreases postprocedural pain. AJR Am. J. Roentgenol. 2006; 186 (Suppl. 5): S30610.
  • 62
    Rhim H, Dodd GD III. Radiofrequency thermal ablation of liver tumors. J. Clin. Ultrasound 1999; 27: 2219. Review.
  • 63
    Takahashi S, Kudo M, Chung H et al. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology 2007; 72 (Suppl. 1): 98103.
  • 64
    Nakazawa T, Kokubu S, Shibuya A et al. Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am. J. Roentgenol. 2007; 188: 4808.
  • 65
    Kim YS, Rhim H, Cho OK, Koh BH, Kim Y. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors. Eur. J. Radiol. 2006; 59: 43241.
  • 66
    Frich L, Hagen G, Brabrab K et al. Local tumor progression after radiofrequency ablation of colorectal liver metastases: evaluation of ablative margin and three-dimensional volumetric analysis. J. Vasc. Interv. Radiol. 2007; 18: 1134.
  • 67
    Dupuy DE, Goldberg SN Image-guided radiofrequency tumor ablation: challenges and opportunities—part II. J. Vasc. Interv. Radiol. 2001; 12: 113548.
  • 68
    Lencinoni R, Della Pina C, Bartolozzi C. Percutaneous image-guided radiofrequency ablation in the therapeutic management of hepatocellular carcinoma. Abdom. Imaging 2005; 30: 4018.
  • 69
    Frericks BB, Ritz JP, Roggan A, Wolf KJ, Albrecht T. Multipolar radiofrequency ablation of hepatic tumors: initial experience. Radiology 2005; 237: 105662.
  • 70
    Lu DS, Raman SS, Vodopich DJ, Wang M, Sayre J, Lassman C. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the ‘heat sink’ effect. AJR Am. J. Roentgenol. 2002; 1787: 4751.
  • 71
    Kim SK, Lim HK, Ryu JA et al. Radiofrequency ablation of rabbit liver in vivo: effect of the pringle maneuver on pathologic changes in liver surrounding the ablation zone. Korean J. Radiol. 2004; 5: 240.
  • 72
    Patterson EJ, Scudamore CH, Owen DA et al. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann. Surg. 1998; 227: 55965.
  • 73
    Zhang YJ, Liang HH, Chen MS et al. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. Radiology 2007; 244: 599.
  • 74
    Veltri A, Moretto P, Doriguzzi A, Pagano E, Carrara G, Gandini G. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur. Radiol. 2006; 16: 6619.
  • 75
    Meloni MF, Goldberg SN, Livraghi T et al. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. AJR Am. J. Roentgenol. 2001; 177: 37580.
  • 76
    Crocetti L, Lencioni R, Debeni S et al. Targeting liver lesions for radiofrequency ablation: an experimental feasibility study using a CT-US fusion imaging system. Invest. Radiol. 2008; 43: 339.
  • 77
    Minami Y, Kudo M, Chung H et al. Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic images. Oncology 2007; 72 (Suppl. 1): 1116.
  • 78
    Wood BJ, Locklin JK, Remer E, O'Malley CM, Goldfarb D, Kaouk JH. Technologies for guidance of radiofrequency ablation in the multimodality interventional suite of the future. J. Vasc. Interv. Radiol. 2007; 18: 924.
  • 79
    Paudyal B, Oriucho N, Paudyal P et al. Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy. Oncol. Rep. 2007; 18: 1469.
  • 80
    Hakime A, Hines-Peralta A, Peddi H et al. Combination of radiofrequency ablation with antiangiogenic therapy for tumor ablation efficacy: study in mice. Radiology 2007; 244: 46470.
  • 81
    Solazzo SA, Ahmed M, Liu Z, Hines-Peralta AU, Goldberg SN. High-power generator for radiofrequency ablation: larger electrodes and pulsing algorithms in bovine ex vivo and porcine in vivo settings. Radiology 2007; 242: 74350.
  • 82
    Goldberg SN, Kamel IR, Kruskal JB et al. Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy. AJR Am. J. Roentgenol. 2002; 179: 93101.
  • 83
    Weng DS, Zhou J, Zhou QM et al. Minimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomas. J. Immunother. 2008; 31: 6371.
  • 84
    Fagnoni FF, Zerbibi A, Pelosi G, Missale G. Combination of radiofrequency ablation and immunotherapy. Front. Biosci. 2008; 1: 36981.
  • 85
    El-Seraq HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008; 134: 175263.
  • 86
    Ng KK, Poon RT. Current treatment strategy for hepatocellular carcinoma. Saudi Med. J. 2007; 28: 13308.